The Roche ATHENA trial is designed to answer current medical and scientific questions about the importance of testing for human papillomavirus ( HPV ) genotypes in cervical cancer screening and to provide additional information about the specific HPV genotypes that put a woman at highest risk for developing cervical cancer .